{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T15:57:21Z","timestamp":1789228641344,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Robotic Surg"],"DOI":"10.1007\/s11701-026-03646-5","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:31:20Z","timestamp":1784539880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of short- and long-term outcomes of robotic versus laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant immunochemotherapy: a single-center propensity score matched study"],"prefix":"10.1007","volume":"20","author":[{"given":"Weijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"5","key":"3646_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift AP, Wenker TN, El-Serag HB (2023) Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Reviews Clin Oncol 20(5):338\u2013349. https:\/\/doi.org\/10.1038\/s41571-023-00747-0","journal-title":"Nat Reviews Clin Oncol"},{"key":"3646_CR2","doi-asserted-by":"publisher","unstructured":"Chen Y, Jia K, Xie Y et al (2025) The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis. J Hematol Oncol 18(1). https:\/\/doi.org\/10.1186\/s13045-025-01698-y","DOI":"10.1186\/s13045-025-01698-y"},{"key":"3646_CR3","doi-asserted-by":"publisher","first-page":"104082","DOI":"10.1016\/j.critrevonc.2023.104082","volume":"198","author":"C Wei","year":"2024","unstructured":"Wei C, Du X, Hu J et al (2024) Perioperative chemotherapy versus adjuvant chemotherapy in patients with resectable gastric cancer: A systematic review with meta-analysis. Crit Rev Oncol\/Hematol 198:104082. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104082","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"3646_CR4","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.20.02914","volume":"39","author":"YK Kang","year":"2021","unstructured":"Kang YK, Yook JH, Park YK et al (2021) PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer. J Clin Oncol 39:2903\u20132913. https:\/\/doi.org\/10.1200\/JCO.20.02914","journal-title":"J Clin Oncol"},{"key":"3646_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ et al (2022) Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 20:167\u2013192. https:\/\/doi.org\/10.6004\/jnccn.2022.0008","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"3646_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41591-023-02721-w","volume":"30","author":"S-Q Yuan","year":"2024","unstructured":"Yuan S-Q, Nie R-C, Jin Y et al (2024) Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial. Nat Med 30(2):552\u2013559. https:\/\/doi.org\/10.1038\/s41591-023-02721-w","journal-title":"Nat Med"},{"key":"3646_CR7","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/JCO-25-00486","volume":"43","author":"K Shitara","year":"2025","unstructured":"Shitara K, Rha SY, Wyrwicz L et al (2025) Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study. J Clin Oncol 43:3152\u20133159. https:\/\/doi.org\/10.1200\/JCO-25-00486","journal-title":"J Clin Oncol"},{"key":"3646_CR8","doi-asserted-by":"publisher","unstructured":"Cui H, Zhang K, Wei B et al (2023) Application and challenge of neoadjuvant immunotherapy on perioperative treatment for locally advanced gastric cancer. Int J Surg 289\u2013294. https:\/\/doi.org\/10.1016\/j.ijsu.2023.102345","DOI":"10.1016\/j.ijsu.2023.102345"},{"issue":"2","key":"3646_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41584-020-00546-2","volume":"17","author":"LC Cappelli","year":"2020","unstructured":"Cappelli LC, Bingham CO, III (2020) Spectrum and impact of checkpoint inhibitor-induced irAEs. Nat Rev Rheumatol 17(2):69\u201370. https:\/\/doi.org\/10.1038\/s41584-020-00546-2","journal-title":"Nat Rev Rheumatol"},{"key":"3646_CR10","doi-asserted-by":"publisher","unstructured":"Zhang T, Lv H, Li J et al (2024) The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment. Front Immunol 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1503316","DOI":"10.3389\/fimmu.2024.1503316"},{"key":"3646_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/jamasurg.2023.0096","volume":"158","author":"T Etoh","year":"2023","unstructured":"Etoh T, Ohyama T, Sakuramoto S et al (2023) Five-year survival outcomes of laparoscopy-assisted vs open distal gastrectomy for advanced gastric cancer: the JLSSG0901 randomized clinical trial. JAMA Surg 158:445\u2013454. https:\/\/doi.org\/10.1001\/jamasurg.2023.0096","journal-title":"JAMA Surg"},{"key":"3646_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jamasurg.2022.2749","volume":"157","author":"SY Son","year":"2022","unstructured":"Son SY, Hur H, Hyung WJ et al (2022) Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: 5-Year Outcomes of the KLASS-02 Randomized Clinical Trial. JAMA Surg 157:879\u2013886. https:\/\/doi.org\/10.1001\/jamasurg.2022.2749","journal-title":"JAMA Surg"},{"key":"3646_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s004640080154","volume":"16","author":"M Hashizume","year":"2002","unstructured":"Hashizume M, Shimada M, Tomikawa M et al (2002) Early experiences of endoscopic procedures in general surgery assisted by a computer-enhanced surgical system. Surg Endosc 16:1187\u20131191. https:\/\/doi.org\/10.1007\/s004640080154","journal-title":"Surg Endosc"},{"issue":"1","key":"3646_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00464-020-08253-5","volume":"36","author":"Y Tian","year":"2021","unstructured":"Tian Y, Cao S, Kong Y et al (2021) Short- and long-term comparison of robotic and laparoscopic gastrectomy for gastric cancer by the same surgical team: a propensity score matching analysis. Surg Endosc 36(1):185\u2013195. https:\/\/doi.org\/10.1007\/s00464-020-08253-5","journal-title":"Surg Endosc"},{"issue":"9","key":"3646_CR15","doi-asserted-by":"publisher","first-page":"10485","DOI":"10.1002\/cam4.5785","volume":"12","author":"Z Jia","year":"2023","unstructured":"Jia Z, Cao S, Meng C et al (2023) Intraoperative performance and outcomes of robotic and laparoscopic total gastrectomy for gastric cancer: A high-volume center retrospective propensity score matching study. Cancer Med 12(9):10485\u201310498. https:\/\/doi.org\/10.1002\/cam4.5785","journal-title":"Cancer Med"},{"issue":"1","key":"3646_CR16","doi-asserted-by":"publisher","first-page":"107312","DOI":"10.1016\/j.ejso.2023.107312","volume":"50","author":"C Meng","year":"2024","unstructured":"Meng C, Cao S, Yu Q et al (2024) Short- and long-term comparison of robotic versus laparoscopic gastrectomy for gastric cancer patients with BMI\u2009\u2265\u200930 kg\/m2: A propensity score matched analysis. Eur J Surg Oncol 50(1):107312. https:\/\/doi.org\/10.1016\/j.ejso.2023.107312","journal-title":"Eur J Surg Oncol"},{"key":"3646_CR17","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s00464-025-11626-3","volume":"39","author":"Q Liu","year":"2025","unstructured":"Liu Q, Meng C, Cao S et al (2025) Comparison of short- and long-term outcomes of robotic versus laparoscopic gastrectomy for locally advanced gastric cancer after neoadjuvant therapy: a high-volume center retrospective study with propensity score matching. Surg Endosc 39:2814\u20132827. https:\/\/doi.org\/10.1007\/s00464-025-11626-3","journal-title":"Surg Endosc"},{"key":"3646_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/SLA.0000000000006585","volume":"282","author":"Z Jia","year":"2025","unstructured":"Jia Z, Cao S, Wang D et al (2025) Identification and categorization of technical errors and hazard zones of robotic versus laparoscopic total gastrectomy for gastric cancer: a single-center prospective randomized controlled study. Ann Surg 282:37\u201345. https:\/\/doi.org\/10.1097\/SLA.0000000000006585","journal-title":"Ann Surg"},{"issue":"4","key":"3646_CR19","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.3390\/cancers14041054","volume":"14","author":"S Takei","year":"2022","unstructured":"Takei S, Kawazoe A, Shitara K (2022) The New Era of Immunotherapy in Gastric Cancer. Cancers 14(4):1054. https:\/\/doi.org\/10.3390\/cancers14041054","journal-title":"Cancers"},{"issue":"5","key":"3646_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10120-024-01523-4","volume":"27","author":"A Ooki","year":"2024","unstructured":"Ooki A, Osumi H, Yoshino K, Yamaguchi K (2024) Potent therapeutic strategy in gastric cancer with microsatellite instability-high and\/or deficient mismatch repair. Gastric Cancer 27(5):907\u2013931. https:\/\/doi.org\/10.1007\/s10120-024-01523-4","journal-title":"Gastric Cancer"},{"key":"3646_CR21","unstructured":"US Department of Health and Human Services (2017) Common terminology criteria for adverse events (CTCAE). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm"},{"issue":"4suppl","key":"3646_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1200\/jco.2020.38.4_suppl.347","volume":"38","author":"Y Ohya","year":"2020","unstructured":"Ohya Y, Ando T, Ueda A et al (2020) Prognostic impact of immune-related adverse events with nivolumab in patients with advanced gastric cancer: A multicenter retrospective analysis. J Clin Oncol 38(4suppl):347\u2013347. https:\/\/doi.org\/10.1200\/jco.2020.38.4_suppl.347","journal-title":"J Clin Oncol"},{"key":"3646_CR23","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24:1\u201321. https:\/\/doi.org\/10.1007\/s10120-020-01042-y","DOI":"10.1007\/s10120-020-01042-y"},{"key":"3646_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54980.ac","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54980.ac","journal-title":"Ann Surg"},{"issue":"4","key":"3646_CR25","doi-asserted-by":"publisher","first-page":"e225557","DOI":"10.1001\/jamanetworkopen.2022.5557","volume":"5","author":"J-X Lin","year":"2022","unstructured":"Lin J-X, Tang Y-H, Lin G-J et al (2022) Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy. JAMA Netw Open 5(4):e225557. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.5557","journal-title":"JAMA Netw Open"},{"key":"3646_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","volume":"25","author":"K Shitara","year":"2024","unstructured":"Shitara K, Rha SY, Wyrwicz LS et al (2024) Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study. Lancet Oncol 25:212\u2013224. https:\/\/doi.org\/10.1016\/S1470-2045(23)00541-7","journal-title":"Lancet Oncol"},{"key":"3646_CR27","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1097\/js9.0000000000001357","volume":"110","author":"DX Wang","year":"2024","unstructured":"Wang DX, Liu H, Tian JC et al (2024) Neoadjuvant immunotherapy based on PD-1\/L1 inhibitors for gastrointestinal tumors: a review of the rationale and clinical advances. Int J Surg 110:3707\u20133722. https:\/\/doi.org\/10.1097\/js9.0000000000001357","journal-title":"Int J Surg"},{"key":"3646_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.585006","author":"H Yang","year":"2021","unstructured":"Yang H, Zhang W-H et al (2021) Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study. Front Oncol. 11https:\/\/doi.org\/10.3389\/fonc.2021.585006","journal-title":"Front Oncol"},{"key":"3646_CR29","doi-asserted-by":"publisher","unstructured":"Li W, Wei S-J (2024) Perioperative outcomes of robot-assisted versus laparoscopic distal gastrectomy for gastric cancer: a systematic review and meta-analysis of propensity score matching studies. J Robotic Surg 18(1). https:\/\/doi.org\/10.1007\/s11701-024-02038-x","DOI":"10.1007\/s11701-024-02038-x"},{"key":"3646_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijsu.2020.07.053","volume":"82","author":"GP Guerrini","year":"2020","unstructured":"Guerrini GP, Esposito G, Magistri P et al (2020) Robotic versus laparoscopic gastrectomy for gastric cancer: The largest meta-analysis. Int J Surg 82:210\u2013228. https:\/\/doi.org\/10.1016\/j.ijsu.2020.07.053","journal-title":"Int J Surg"},{"key":"3646_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11701-023-01801-w","volume":"18","author":"S Chatterjee","year":"2024","unstructured":"Chatterjee S, Das S, Ganguly K, Mandal D (2024) Advancements in robotic surgery: innovations, challenges and future prospects. J Robot Surg 18:28. https:\/\/doi.org\/10.1007\/s11701-023-01801-w","journal-title":"J Robot Surg"},{"issue":"3","key":"3646_CR32","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/sla.0000000000004181","volume":"272","author":"AK Arrington","year":"2020","unstructured":"Arrington AK, O\u2019Grady et al (2020) Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers. Ann Surg 272(3):438\u2013446. https:\/\/doi.org\/10.1097\/sla.0000000000004181","journal-title":"Ann Surg"},{"issue":"1","key":"3646_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/SLA.0000000000001296","volume":"263","author":"HI Kim","year":"2016","unstructured":"Kim HI, Han SU, Yang HK et al (2016) Multicenter prospective comparative study of robotic versus laparoscopic gastrectomy for gastric adenocarcinoma. Ann Surg 263(1):103\u2013109. https:\/\/doi.org\/10.1097\/SLA.0000000000001296","journal-title":"Ann Surg"},{"issue":"9","key":"3646_CR34","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.1007\/s00464-023-10122-w","volume":"37","author":"Y Tian","year":"2023","unstructured":"Tian Y, Guo H, Yiyang, Hu et al (2023) Safety and Efficacy of Robotic-Assisted versus Laparoscopic Distal Gastrectomy after Neoadjuvant Chemotherapy for Advanced Gastric Cancer. Surg Endosc 37(9):6761\u20136770. https:\/\/doi.org\/10.1007\/s00464-023-10122-w","journal-title":"Surg Endosc"},{"key":"3646_CR35","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/SLA.0000000000006603","volume":"282","author":"Y Tian","year":"2025","unstructured":"Tian Y, Cao S, Li L et al (2025) Three-year survival outcomes of patients with enhanced recovery after surgery versus conventional care in laparoscopic distal gastrectomy: the GISSG1901 randomized clinical trial. Ann Surg 282:46\u201355. https:\/\/doi.org\/10.1097\/SLA.0000000000006603","journal-title":"Ann Surg"},{"key":"3646_CR36","doi-asserted-by":"publisher","unstructured":"Lu J, Xu B, Zheng H-L et al (2024) Robotic versus laparoscopic distal gastrectomy for resectable gastric cancer: a randomized phase 2 trial. Nat Commun 15(1). https:\/\/doi.org\/10.1038\/s41467-024-49013-6","DOI":"10.1038\/s41467-024-49013-6"},{"key":"3646_CR37","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jama.2025.8123","volume":"334","author":"Q Feng","year":"2025","unstructured":"Feng Q, Yuan W, Li T et al (2025) Robotic vs Laparoscopic Surgery for Middle and Low Rectal Cancer: The REAL Randomized Clinical Trial. JAMA 334:136\u2013148. https:\/\/doi.org\/10.1001\/jama.2025.8123","journal-title":"JAMA"},{"issue":"2","key":"3646_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jamcollsurg.2015.04.024","volume":"221","author":"S Gholami","year":"2015","unstructured":"Gholami S, Janson L, Worhunsky DJ et al (2015) Number of Lymph Nodes Removed and Survival after Gastric Cancer Resection: An Analysis from the US Gastric Cancer Collaborative. J Am Coll Surg 221(2):291\u2013299. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.04.024","journal-title":"J Am Coll Surg"},{"key":"3646_CR39","doi-asserted-by":"publisher","unstructured":"Chen G, Wang J, Chen K et al (2021) Relationship Between Postoperative Complications and the Prognosis of Gastric Carcinoma Patients Who Underwent Surgical Resection: A Systematic Review and Meta-Analysis. Cancer Control 28. https:\/\/doi.org\/10.1177\/10732748211011955","DOI":"10.1177\/10732748211011955"},{"key":"3646_CR40","doi-asserted-by":"publisher","unstructured":"Chatterjee S, Das S, Ganguly K, Mandal D (2024) Advancements in robotic surgery: innovations, challenges and future prospects. J Robotic Surg 18(1). https:\/\/doi.org\/10.1007\/s11701-023-01801-w","DOI":"10.1007\/s11701-023-01801-w"}],"container-title":["Journal of Robotic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11701-026-03646-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11701-026-03646-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:31:23Z","timestamp":1784539883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11701-026-03646-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3646"],"URL":"https:\/\/doi.org\/10.1007\/s11701-026-03646-5","relation":{},"ISSN":["1863-2491"],"issn-type":[{"value":"1863-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"24 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics review committee of the Affiliated Hospital of Qingdao University granted approval for this study (Approval Number QYFY WZLL 50039).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave informed consent.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"682"}}